Findings

What do systematic reviews say?

5 questions · 5 findings · 1 reviews

No studies found 0 · 0%GRADE not reported 0 · 0%Very low 0 · 0%Low 3 · 60%Moderate 1 · 20%High 1 · 20%

Mortality Clinically · people with hepatic encephalopathy

Branched‐chain amino acids (BCAA) showed no clear difference in mortality Clinically compared with control (moderate certainty).

1 finding from 1 review

Branched‐chain amino acids for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 0.88 [0.69, 1.11]
15 studies · 760 participants
Moderate

Hepatic encephalopathy · people with hepatic encephalopathy

Branched‐chain amino acids (BCAA) leads to lower hepatic encephalopathy Psychometric and clinical assessments compared with control (high certainty).

1 finding from 1 review

Branched‐chain amino acids for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 0.73 [0.61, 0.88]
16 studies · 827 participants
High

Nausea and diarrhoea Clinically · people with hepatic encephalopathy

Branched‐chain amino acids (BCAA) showed no clear difference in nausea and diarrhoea Clinically compared with control (low certainty).

1 finding from 1 review

Branched‐chain amino acids for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
RR 3.39 [0.7, 16.46]
5 studies · 945 participants
Low

Albumin Laboratory assessment · people with hepatic encephalopathy

1 finding from 1 review

Branched‐chain amino acids for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 176 participants
Low

Nitrogen balance Laboratory assessment · people with hepatic encephalopathy

1 finding from 1 review

Branched‐chain amino acids for people with hepatic encephalopathy 2017 · Cochrane Headline outcomes only
no estimate extracted
3 studies · 108 participants
Low